Home
毕诺济生物

毕诺济生物 Market Share Analysis for February 2026

我们专注于细胞治疗领域的前沿探索，致力于科研成果的临床转化，开发针对肿瘤和自体免疫性疾病的创新疗法。

Industry: N/A

Domainbennubiotx.com

Year Founded--

Employees51 - 200

Annual Revenue--

毕诺济生物

毕诺济生物 (including company regionals)

bennubiotx.com

See more website traffic and engagement information

Total visits to 毕诺济生物's top domains

Understand 毕诺济生物 market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bennubiotx.com--

See more with Sales Intelligence

Avg. visit duration in 毕诺济生物's top domains

Analyze 毕诺济生物 engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

bennubiotx.com--

See more with Sales Intelligence

Avg. pageviews on 毕诺济生物's top domains

See how 毕诺济生物 keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bennubiotx.com--

See more with Sales Intelligence

毕诺济生物 top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by 毕诺济生物

These are the website technologies, by industry, used by 毕诺济生物 top domains

Content Management System (2)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

Baidu Ads

Conversion & Analytics (1)

Baidu Analytics

More Technologies

2

See all

News & Signals from 毕诺济生物

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBennu Biotherapeutics is developing Treg therapy for solid tumors and autoimmune diseases.Bennu Biotherapeutics is focused on developing T-cell therapies to address T-cell exhaustion, offering TIL, TCR-T, and Treg therapy for solid tumors and autoimmune diseases.